glp-1 drugs safe GLP-1s for Weight Loss: What You Need to Know Scientists cautiously suggest GLP-1s are

Clinical data shows GLP-1 constipation typically peaks around weeks 3-6 and begins to stabilize by week 10

Saxenda US, Package Insert (Novo Nordisk, 2018)

Setmelanotide Setmelanotide is a melanocortin-4 receptor (MC4R) agonist approved to treat genetic obesity due to pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiencies, as well as BardetBiedl syndrome (BBS), in patients aged 2 years and older [45,46,47]

The patients ended the trial at a healthier ratio

In theory, this could pave the way for even greater efficacy for GLP-1 treatments while also achieving an important reduction in the currently high rate of adverse GI events

Food and Drug Administration (FDA) approved Wegovy (semaglutide) for reducing the risk of major cardiovascular events, heart attack, stroke, or death, in adults with obesity and existing cardiovascular disease